Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 4 studies | 25% ± 7% | |
hepatocyte | 3 studies | 39% ± 32% |
Insufficient scRNA-seq data for expression of DHODH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 8881.19 | 226 / 226 | 100% | 18.19 | 405 / 406 |
prostate | 100% | 654.87 | 245 / 245 | 100% | 7.74 | 500 / 502 |
brain | 99% | 408.90 | 2626 / 2642 | 100% | 8.41 | 705 / 705 |
uterus | 100% | 729.11 | 170 / 170 | 99% | 7.05 | 456 / 459 |
kidney | 100% | 608.38 | 89 / 89 | 99% | 7.27 | 892 / 901 |
lung | 100% | 612.33 | 576 / 578 | 99% | 6.52 | 1147 / 1155 |
breast | 100% | 731.94 | 459 / 459 | 99% | 5.75 | 1106 / 1118 |
esophagus | 100% | 541.64 | 1445 / 1445 | 99% | 4.98 | 181 / 183 |
skin | 100% | 615.46 | 1808 / 1809 | 99% | 7.98 | 467 / 472 |
bladder | 100% | 623.05 | 21 / 21 | 99% | 6.74 | 498 / 504 |
intestine | 100% | 584.97 | 965 / 966 | 98% | 7.45 | 518 / 527 |
ovary | 100% | 776.99 | 180 / 180 | 98% | 5.10 | 422 / 430 |
thymus | 100% | 762.67 | 653 / 653 | 98% | 5.13 | 591 / 605 |
pancreas | 99% | 399.84 | 325 / 328 | 98% | 5.12 | 174 / 178 |
stomach | 100% | 482.58 | 358 / 359 | 97% | 6.37 | 277 / 286 |
adrenal gland | 100% | 613.54 | 258 / 258 | 95% | 4.56 | 218 / 230 |
adipose | 100% | 827.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.78 | 29 / 29 |
muscle | 100% | 608.87 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 733.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.12 | 1 / 1 |
blood vessel | 100% | 484.35 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1037.21 | 844 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 6.24 | 76 / 80 |
peripheral blood | 74% | 398.33 | 684 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006207 | Biological process | 'de novo' pyrimidine nucleobase biosynthetic process |
GO_0009220 | Biological process | pyrimidine ribonucleotide biosynthetic process |
GO_0006225 | Biological process | UDP biosynthetic process |
GO_0044205 | Biological process | 'de novo' UMP biosynthetic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0106430 | Molecular function | dihydroorotate dehydrogenase (quinone) activity |
GO_0004152 | Molecular function | dihydroorotate dehydrogenase activity |
GO_0004151 | Molecular function | dihydroorotase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DHODH |
Protein name | Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) Dihydroorotate dehydrogenase (quinone) |
Synonyms | |
Description | FUNCTION: Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway. . FUNCTION: Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway. . |
Accessions | I3NI32 I3L449 ENST00000576145.1 J3QRJ4 ENST00000572887.5 J3QRQ3 ENST00000219240.9 ENST00000571288.6 ENST00000574309.5 Q02127 |